199 related articles for article (PubMed ID: 20031783)
1. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients.
Weintraub WS; Boden WE; Zhang Z; Kolm P; Zhang Z; Spertus JA; Hartigan P; Veledar E; Jurkovitz C; Bowen J; Maron DJ; O'Rourke R; Dada M; Teo KK; Goeree R; Barnett PG;
Circ Cardiovasc Qual Outcomes; 2008 Sep; 1(1):12-20. PubMed ID: 20031783
[TBL] [Abstract][Full Text] [Related]
2. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
Mahoney EM; Mehta S; Yuan Y; Jackson J; Chen R; Gabriel S; Lamy A; Culler S; Caro J; Yusuf S; Weintraub WS;
Am Heart J; 2006 Jan; 151(1):219-27. PubMed ID: 16368322
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
4. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
Aasa M; Henriksson M; Dellborg M; Grip L; Herlitz J; Levin LA; Svensson L; Janzon M
Am Heart J; 2010 Aug; 160(2):322-8. PubMed ID: 20691839
[TBL] [Abstract][Full Text] [Related]
5. Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
Teo KK; Sedlis SP; Boden WE; O'Rourke RA; Maron DJ; Hartigan PM; Dada M; Gupta V; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
J Am Coll Cardiol; 2009 Sep; 54(14):1303-8. PubMed ID: 19778673
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).
Claude J; Schindler C; Kuster GM; Schwenkglenks M; Szucs T; Buser P; Osswald S; Kaiser C; Grädel C; Estlinbaum W; Rickenbacher P; Pfisterer M;
Eur Heart J; 2004 Dec; 25(24):2195-203. PubMed ID: 15589636
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
Zhang Z; Kolm P; Boden WE; Hartigan PM; Maron DJ; Spertus JA; O'Rourke RA; Shaw LJ; Sedlis SP; Mancini GB; Berman DS; Dada M; Teo KK; Weintraub WS
Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):172-82. PubMed ID: 21304091
[TBL] [Abstract][Full Text] [Related]
9. Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial.
Weintraub WS; Barnett P; Chen S; Hartigan P; Casperson P; O'Rourke R; Boden WE; Lewis C; Veledar E; Becker E; Culler S; Kolm P; Mahoney EM; Dunbar SB; Deaton C; O'Brien B; Goeree R; Blackhouse G; Nease R; Spertus J; Kaufman S; Teo K
Am Heart J; 2006 Jun; 151(6):1180-5. PubMed ID: 16781215
[TBL] [Abstract][Full Text] [Related]
10. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
Hlatky MA; Rogers WJ; Johnstone I; Boothroyd D; Brooks MM; Pitt B; Reeder G; Ryan T; Smith H; Whitlow P; Wiens R; Mark DB
N Engl J Med; 1997 Jan; 336(2):92-9. PubMed ID: 8988886
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
Coleman CI; McKay RG; Boden WE; Mather JF; White CM
Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
[TBL] [Abstract][Full Text] [Related]
13. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
Lindgren P; Stenestrand U; Malmberg K; Jönsson B
Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
[TBL] [Abstract][Full Text] [Related]
14. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
[TBL] [Abstract][Full Text] [Related]
15. Influence of age on revascularization related costs of hospitalization among patients of stable coronary artery disease.
Agarwal S; Banerjee S; Tuzcu EM; Kapadia SR
Am J Cardiol; 2010 Jun; 105(11):1549-54. PubMed ID: 20494660
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial.
Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE;
J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010
[TBL] [Abstract][Full Text] [Related]
17. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
Boden WE; O'Rourke RA; Teo KK; Maron DJ; Hartigan PM; Sedlis SP; Dada M; Labedi M; Spertus JA; Kostuk WJ; Berman DS; Shaw LJ; Chaitman BR; Mancini GB; Weintraub WS;
Am J Cardiol; 2009 Jul; 104(1):1-4. PubMed ID: 19576311
[TBL] [Abstract][Full Text] [Related]
18. Effect of PCI on quality of life in patients with stable coronary disease.
Weintraub WS; Spertus JA; Kolm P; Maron DJ; Zhang Z; Jurkovitz C; Zhang W; Hartigan PM; Lewis C; Veledar E; Bowen J; Dunbar SB; Deaton C; Kaufman S; O'Rourke RA; Goeree R; Barnett PG; Teo KK; Boden WE; ; Mancini GB
N Engl J Med; 2008 Aug; 359(7):677-87. PubMed ID: 18703470
[TBL] [Abstract][Full Text] [Related]
19. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Beinart SC; Kolm P; Veledar E; Zhang Z; Mahoney EM; Bouin O; Gabriel S; Jackson J; Chen R; Caro J; Steinhubl S; Topol E; Weintraub WS
J Am Coll Cardiol; 2005 Sep; 46(5):761-9. PubMed ID: 16139122
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
Holper EM; Addo T
Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
